Outcome of Board Meeting
FCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 21.6 pts more than Nifty Microcap 250 and 21.9 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Fineotex Chemical reported strong Q4 FY26 results with consolidated revenue jumping 161.91% YoY to Rs. 313.73 Cr and PAT growing 117.56% to Rs. 43.80 Cr. For the full year FY26, consolidated revenue increased 44.79% to Rs. 772.23 Cr while PAT rose 14.50% to Rs. 125.01 Cr. The company declared a final dividend of Rs. 0.05 per share in addition to the Rs. 0.80 interim dividend already paid, totaling Rs. 14.99 Cr for FY26 (up 63.5% from Rs. 9.17 Cr in FY25). Volume grew 131% YoY in Q4 and ROIC stood at 31.10%. The auditors issued unmodified opinions on both standalone and consolidated financial statements. During the year, the company executed a 4:1 bonus share issuance and 1:1 stock split.
Strong revenue and profit growth demonstrates solid business momentum, though PAT growth lagging revenue growth indicates margin compression. The significant dividend increase reflects confidence in financial health. Shareholders should note negative operating cash flow and substantial working capital buildup which warrant monitoring.